Trial Profile
The Effect Of Ramipril On Endothelial Function and Endothelial Progenitor Cells In Patients With Systemic Lupus Erythematosus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2013
Price :
$35
*
At a glance
- Drugs Ramipril (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- 29 Nov 2013 New trial record
- 27 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.